PODCAST

Endocrinology

ReachMD

science & medicine medicine

All Episodes

00:00:00

Latest Clinical Trial Outcomes and Breakthroughs for FCS

Endocrinology ·

2025/05/30

Guest: Daniel Gaudet, MD, PhD Guest: Pam R. Taub, MD, FACC, FASPC There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of

00:00:00

Remnant Cholesterol: The Missing Link in ASCVD risk

Endocrinology ·

2025/05/30

Guest: Børge G. Nordestgaard, MD, DMSc Guest: Kausik Ray, MBChB, MD, MPhil There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence

00:00:00

The Road Ahead: What's on the Horizon for FCS and...

Endocrinology ·

2025/05/30

Guest: Pam R. Taub, MD, FACC, FASPC Guest: Prof. Kausik Ray There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical

00:00:00

SHTG: Defining the Unmet Clinical Need

Endocrinology ·

2025/05/30

Guest: Pam R. Taub, MD, FACC, FASPC Guest: Kausik Ray, MBChB, MD, MPhil There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of

00:00:00

APOC3 Inhibition: A Novel Approach to Lowering TGs

Endocrinology ·

2025/05/30

00:00:00

FCS: Enhancing the Diagnosis

Endocrinology ·

2025/05/30

Guest: Daniel Gaudet, MD, PhD There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.

00:00:00

SHTG: Decoding the Latest Clinical Trial Outcomes

Endocrinology ·

2025/05/30

00:00:00

Setting the Bar: Guideline-Recommended Treatment in...

Endocrinology ·

2025/05/30

00:00:00

Targeting Mixed Hyperlipidemia with APOC3 Inhibition

Endocrinology ·

2025/05/30

00:00:00

Evaluating Endocrine Complications in DMD Patients:...

Endocrinology ·

2024/08/22

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Nadia Merchant, MD Guest: Melody Shi, MD Guest: Despoina Galetaki, MD Steroids are one of the main treatments for patients with Duchenne muscular dystrophy (DMD), but prolonged steroid use can come with many endocrine side effects, like weight gain, insulin resistance, and adrenal insufficiency. To learn more about these endocrine complications and surveillance, a recent survey was conducted, and here to share the results with

00:00:00

Leading the Charge on Obesity Management: The...

Endocrinology ·

2024/04/26

Host: Daniel Bessesen, MD Guest: Joanna Miragaya Guest: Jaime Almandoz, MD, MBA, FTOS Gain experts’ insights and tools for endocrinology specialists to use to support and empower community-based colleagues in successful and sustainable obesity management practices.

00:00:00

Idiopathic Pulmonary Fibrosis: The Role of Radiology...

Endocrinology ·

2024/04/25

Host: Jonathan Chung, MD Host: Seth Kligerman, MD Learn from experts about differentiating idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases and the role of radiology in effectively diagnosing IPF with a multidisciplinary team approach.

12 results

Endocrinology

All Episodes

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe